0

Close
 
2023
Injection Pen Market

Injection Pen Market

by Type (Disposable injection pen, Reusable injection pen), by Therapy (Diabetes, Growth Hormone, Osteoporosis, Fertility, Others), by End Users (Home-care Settings, Hospital and clinics): Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Medical Devices & Supplies
Report Code: A07629
Mar 2023 | Pages: 428
Tables: 128
Charts: 75

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

Injection Pen Market Research, 2031

The global injection pen market size was valued at $ 37,899.00 million in 2021 and is projected to reach $80,511.51 million by 2031, growing at a CAGR of 7.8% from 2022 to 2031. An injection pen is a medical device used to administer injections. It consists of a needle, a syringe and a pen-like device with a plunger that controls the amount of medication administered. It is commonly used to administer insulin and other medications. There are disposable and reusable types of injection pens available in the market. Disposable pens are preloaded with drug and are thrown away after the drug cartridge is empty. Whereas reusable pens work with drug cartridges that can be loaded into the pen and then thrown away once the drug is used, leaving the pen ready for the next cartridge. 

The growth of the injection pen market increased during the lockdown period owing to an increase in the number of diabetic patients who are at higher risk of getting affected by COVID-19. Moreover, people with diabetes require continuous access to insulin (administrated with injection pens) and care. Thus, the adoption of injection pens has increased during the pandemic to manage the blood sugar levels of diabetic patients.

Injection Pen Market

Market dynamics 

The key factors that drive the growth of the injection pen market share are increase in prevalence of chronic diseases such as cancer and diabetes, and surge in geriatric population. For instance, according to the report published by International Diabetes Federation in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. In addition, more than 1.2 million children and adolescents (0-19 years) are living with type 1 diabetes and 541 million adults are at increased risk of developing type 2 diabetes. Thus, increase in prevalence of chronic diseases, and rise in awareness of self-injectables devices are the major factors driving the growth of the injection pen market growth.

Moreover, the rise in adoption of technologically advanced reusable injection pens among patients suffering from diabetes is the key factor that boosts the market growth. For instance, in 2020, Medtronic Plc launched InPen, a reusable smart injection pen for people living with diabetes. The pen uses Bluetooth technology to calculate insulin doses and to estimate carbohydrates for meals.

Furthermore, the increase in adoption of automated injection pens is driving the growth of the injection pen market share. Automated injection pens are designed to be easy to use and are gaining popularity among healthcare providers, as they can provide accuracy, safety, and convenience in drug delivery. The demand for injection pens is not only limited to developed countries, but is also being witnessed in developing countries, owing to rapid increase in geriatric population which is prone to chronic diseases such as diabetes and cancer. These are the factors that fuel the growth of the market. 

However, high cost of injection pen in some regions such as North America and availability of alternative methods for drug delivery restrain the growth of the injection pen market size. Conversely, rise in prevalence of chronic diseases and increase in demand for injection pen for insulin from emerging economies owing to rise in diabetic cases may open up new market potential for injection pen and is expected to provide a lucrative opportunity for the growth of the market during the forecast period.‐¯  

Segmental Overview 

The injection pen market is segmented on the basis of type, therapy, end-user, and region. By type, the market is bifurcated into disposable injection pen and reusable injection pen. By therapy, the market is divided into diabetes, growth hormone, osteoporosis, fertility, and others. By end user, the market is categorized into home-care settings and hospital & clinics. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  

By type 

The injection pen market is segmented into disposable injection pens and reusable injection pens. The disposable injection pens segment accounted for the largest share of the market in 2021 and is anticipated to remain dominant during the forecast period, owing to rise in the adoption of disposable injection pens across the world to prevent the risk of cross-contamination and needle stick injuries associated with reusable injection pens.

Injection Pen Market

 

By therapy 

The injection pen market is segmented into diabetes, growth hormones, osteoporosis, fertility and others. The diabetes segment accounted for the largest share of the market in 2021 and is anticipated to remain dominant during the forecast period This is attributed to rise in the prevalence of diabetics and increase in the number of geriatric population. According to Caspersen et al, in 2020, about 10.9 million people aged above 65 years were estimated to have been diagnosed with diabetes in the U.S, and this number is projected to reach 26.7 million by 2050. 

Injection Pen Market

By end user 

The injection pen market is bifurcated into home-care settings and hospital & clinics. The home-care settings segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to increase in awareness regarding injection pens, rise in disposable income, surge in consumer expenditure on healthcare, and rise in adoption of innovative drug delivery devices among the patients to manage diseases by staying at home.  

Injection Pen Market

By region 

The injection pen market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the injection pen market in 2021 and is expected to maintain its dominance during the forecast period. The U.S. has been the biggest contributor to the growth of the injection pens market in North America due to the increase in prevalence of chronic diseases and rise in demand for safe and effective delivery of medications. North America also benefits from the presence of several major players in the injection pens market, such as Sanofi, Eli Lilly, Novo Nordisk, and Becton Dickinson, which have invested heavily in research and development to come up with innovative products.  

Asia-Pacific is expected to witness growth at the highest rate during the injection pen market forecast. The market growth in this region is attributed to rise in the prevalence of chronic diseases like diabetes and cancer among the adult population, increase in number of geriatric patient population, and surge in the investment for injection pen products development drive the growth of the Asia-Pacific injection pen market. In addition, an increase in the adoption of key strategies like acquisition, product launch, and product approval by market players boost the market growth. For instance, in 2021, Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. launched interchangeable biosimilars SEMGLEE injection pen, to help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2 diabetes. 

Injection Pen Market

Competition Analysis 

The report provides competitive analysis and profiles of the major players in the injection pen market, such as Eli Lily and Company, Novo Nordisk A/S, Sanofi, Biocon Limited, AstraZeneca, Pfizer Inc, Becton, Dickinson and Company, Ypsomed AG, Novartis AG and Merck KGaA.  

Recent product upgrade/development in injection pen market

  • In February 2023, AstraZeneca and Amgen’s Tezspire (tezepelumab) pre-filled pen was approved in the U.S. by the U.S. Food and Drug Administration (FDA). Tezspire pre-filled pen is used for self-administration in patients aged 12 years and older with severe asthma. Thus, launch of the new injection pen device will help the company to gain a strong foothold in the injection pen industry.
  • In October 2020, Ypsomed AG developed the YpsoMate Zero the world’s first zero carbon emission prefilled autoinjector.  

Recent collaborations in injection pen market

  • In March 2020, Ypsomed AG collaborated with Teva Pharmaceutical Industries Ltd. to launch Teva's drug product AJOVY in the pre-filled YpsoMate 2.25 autoinjector. This collaboration with Teva marks the first commercial market entry of Ypsomed’s YpsoMate 2.25 autoinjector.

 Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the injection pen market analysis from 2021 to 2031 to identify the prevailing injection pen market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the injection pen market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global injection pen market trends, key players, market segments, application areas, and market growth strategies.

 Injection Pen Market Report Highlights

Aspects Details
Market Size By 2031 USD 80.5 billion
Growth Rate CAGR of 7.8%
Forecast period 2021 - 2031
Report Pages 428
By Therapy
  • Growth Hormone
  • Osteoporosis
  • Fertility
  • Others
  • Diabetes
By End Users
  • Home-care Settings
  • Hospital and clinics
By Type
  • Disposable injection pen
  • Reusable injection pen
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Ypsomed AG, Novartis AG, Becton, Dickinson and Company, Biocon, Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Merck Group, AstraZeneca, Sanofi

Analyst Review

According to the insights of CXOs, an increase in awareness about self-injection devices, rise in prevalence of chronic diseases, surge in technological advancement in the field of medical devices, and rise in geriatric population are the factors that drives the growth of the market.   

The injection pen market is expected to witness steady growth in the future. The rise in the prevalence of chronic disease and the increase in demand for home healthcare as well as the rise in cost of hospital visits has made injection pen devices a viable option for many patients. Moreover, increase in the demand for self-injection medical devices and rise in advancement in technology have allowed for the development of injection pen devices that are more accurate and reliable. This, in turn, fuels the market growth. In addition, surge in healthcare expenditure, and rise in reimbursement policy for medical devices are the key factors driving the growth of the market. However, the high cost of the injection pen in some regions and availability of other drug delivery methods hamper the growth of the market during the forecast period.   

North America is expected to dominate the global injection pen market during the forecast period, followed by Europe. In addition, emerging economies such as India, China, Mexico, and Brazil are expected to offer lucrative opportunities owing to rapidly improving healthcare facilities, rise in geriatric population, and increase in prevalence of chronic disease.   

 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in prevalence of chronic disease.
        • 3.4.1.2. Surge in awareness for self-injectables
        • 3.4.1.3. Rise in technological advancement

      • 3.4.2. Restraints

        • 3.4.2.1. Preference for alternative drug delivery modes
        • 3.4.2.2. Increase in the number of needlestick injury

      • 3.4.3. Opportunities

        • 3.4.3.1. High growth potential in developing economies.

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: INJECTION PEN MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Disposable injection pen

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Reusable injection pen

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

  • CHAPTER 5: INJECTION PEN MARKET, BY THERAPY

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Diabetes

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Growth Hormone

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Osteoporosis

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Fertility

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

    • 5.6. Others

      • 5.6.1. Key market trends, growth factors and opportunities

      • 5.6.2. Market size and forecast, by region

      • 5.6.3. Market share analysis by country

  • CHAPTER 6: INJECTION PEN MARKET, BY END USERS

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Home-care Settings

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Hospital and clinics

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

  • CHAPTER 7: INJECTION PEN MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Type

      • 7.2.3. Market size and forecast, by Therapy

      • 7.2.4. Market size and forecast, by End Users

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Type
          • 7.2.5.1.3. Market size and forecast, by Therapy
          • 7.2.5.1.4. Market size and forecast, by End Users
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Type
          • 7.2.5.2.3. Market size and forecast, by Therapy
          • 7.2.5.2.4. Market size and forecast, by End Users
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Type
          • 7.2.5.3.3. Market size and forecast, by Therapy
          • 7.2.5.3.4. Market size and forecast, by End Users

    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Type

      • 7.3.3. Market size and forecast, by Therapy

      • 7.3.4. Market size and forecast, by End Users

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Type
          • 7.3.5.1.3. Market size and forecast, by Therapy
          • 7.3.5.1.4. Market size and forecast, by End Users
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Type
          • 7.3.5.2.3. Market size and forecast, by Therapy
          • 7.3.5.2.4. Market size and forecast, by End Users
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Type
          • 7.3.5.3.3. Market size and forecast, by Therapy
          • 7.3.5.3.4. Market size and forecast, by End Users
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Type
          • 7.3.5.4.3. Market size and forecast, by Therapy
          • 7.3.5.4.4. Market size and forecast, by End Users
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Type
          • 7.3.5.5.3. Market size and forecast, by Therapy
          • 7.3.5.5.4. Market size and forecast, by End Users
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Type
          • 7.3.5.6.3. Market size and forecast, by Therapy
          • 7.3.5.6.4. Market size and forecast, by End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Type

      • 7.4.3. Market size and forecast, by Therapy

      • 7.4.4. Market size and forecast, by End Users

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Type
          • 7.4.5.1.3. Market size and forecast, by Therapy
          • 7.4.5.1.4. Market size and forecast, by End Users
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Type
          • 7.4.5.2.3. Market size and forecast, by Therapy
          • 7.4.5.2.4. Market size and forecast, by End Users
        • 7.4.5.3. Australia
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Type
          • 7.4.5.3.3. Market size and forecast, by Therapy
          • 7.4.5.3.4. Market size and forecast, by End Users
        • 7.4.5.4. India
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Type
          • 7.4.5.4.3. Market size and forecast, by Therapy
          • 7.4.5.4.4. Market size and forecast, by End Users
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Type
          • 7.4.5.5.3. Market size and forecast, by Therapy
          • 7.4.5.5.4. Market size and forecast, by End Users
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Type
          • 7.4.5.6.3. Market size and forecast, by Therapy
          • 7.4.5.6.4. Market size and forecast, by End Users

    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Type

      • 7.5.3. Market size and forecast, by Therapy

      • 7.5.4. Market size and forecast, by End Users

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Type
          • 7.5.5.1.3. Market size and forecast, by Therapy
          • 7.5.5.1.4. Market size and forecast, by End Users
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Type
          • 7.5.5.2.3. Market size and forecast, by Therapy
          • 7.5.5.2.4. Market size and forecast, by End Users
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Type
          • 7.5.5.3.3. Market size and forecast, by Therapy
          • 7.5.5.3.4. Market size and forecast, by End Users
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Type
          • 7.5.5.4.3. Market size and forecast, by Therapy
          • 7.5.5.4.4. Market size and forecast, by End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Eli Lilly and Company

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

    • 9.2. AstraZeneca

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

      • 9.2.7. Key strategic moves and developments

    • 9.3. Ypsomed AG

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

      • 9.3.7. Key strategic moves and developments

    • 9.4. Becton, Dickinson and Company

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Merck Group

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

    • 9.6. Pfizer Inc.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. Novartis AG

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

    • 9.8. Sanofi

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

    • 9.9. Novo Nordisk A/S

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Business performance

    • 9.10. Biocon

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

  • LIST OF TABLES

  • TABLE 01. GLOBAL INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 02. INJECTION PEN MARKET FOR DISPOSABLE INJECTION PEN, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. INJECTION PEN MARKET FOR REUSABLE INJECTION PEN, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. GLOBAL INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 05. INJECTION PEN MARKET FOR DIABETES, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. INJECTION PEN MARKET FOR GROWTH HORMONE, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. INJECTION PEN MARKET FOR OSTEOPOROSIS, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. INJECTION PEN MARKET FOR FERTILITY, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. INJECTION PEN MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. GLOBAL INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 11. INJECTION PEN MARKET FOR HOME-CARE SETTINGS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. INJECTION PEN MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. INJECTION PEN MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. NORTH AMERICA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 15. NORTH AMERICA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 16. NORTH AMERICA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 17. NORTH AMERICA INJECTION PEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 18. U.S. INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 19. U.S. INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 20. U.S. INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 21. CANADA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 22. CANADA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 23. CANADA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 24. MEXICO INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 25. MEXICO INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 26. MEXICO INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 27. EUROPE INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 28. EUROPE INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 29. EUROPE INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 30. EUROPE INJECTION PEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 31. GERMANY INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 32. GERMANY INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 33. GERMANY INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 34. FRANCE INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 35. FRANCE INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 36. FRANCE INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 37. UK INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 38. UK INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 39. UK INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 40. ITALY INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 41. ITALY INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 42. ITALY INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 43. SPAIN INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 44. SPAIN INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 45. SPAIN INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 46. REST OF EUROPE INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 47. REST OF EUROPE INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 48. REST OF EUROPE INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 49. ASIA-PACIFIC INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 50. ASIA-PACIFIC INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 51. ASIA-PACIFIC INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 52. ASIA-PACIFIC INJECTION PEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 53. JAPAN INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 54. JAPAN INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 55. JAPAN INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 56. CHINA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 57. CHINA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 58. CHINA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 59. AUSTRALIA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 60. AUSTRALIA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 61. AUSTRALIA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 62. INDIA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 63. INDIA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 64. INDIA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 65. SOUTH KOREA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 66. SOUTH KOREA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 67. SOUTH KOREA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 68. REST OF ASIA-PACIFIC INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 69. REST OF ASIA-PACIFIC INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 70. REST OF ASIA-PACIFIC INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 71. LAMEA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 72. LAMEA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 73. LAMEA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 74. LAMEA INJECTION PEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 75. BRAZIL INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 76. BRAZIL INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 77. BRAZIL INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 78. SAUDI ARABIA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 79. SAUDI ARABIA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 80. SAUDI ARABIA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 81. SOUTH AFRICA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 82. SOUTH AFRICA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 83. SOUTH AFRICA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 84. REST OF LAMEA INJECTION PEN MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 85. REST OF LAMEA INJECTION PEN MARKET, BY THERAPY, 2021-2031 ($MILLION)
    TABLE 86. REST OF LAMEA INJECTION PEN MARKET, BY END USERS, 2021-2031 ($MILLION)
    TABLE 87. ELI LILLY AND COMPANY: KEY EXECUTIVES
    TABLE 88. ELI LILLY AND COMPANY: COMPANY SNAPSHOT
    TABLE 89. ELI LILLY AND COMPANY: PRODUCT SEGMENTS
    TABLE 90. ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
    TABLE 91. ASTRAZENECA: KEY EXECUTIVES
    TABLE 92. ASTRAZENECA: COMPANY SNAPSHOT
    TABLE 93. ASTRAZENECA: PRODUCT SEGMENTS
    TABLE 94. ASTRAZENECA: PRODUCT PORTFOLIO
    TABLE 95. ASTRAZENECA: KEY STRATERGIES
    TABLE 96. YPSOMED AG: KEY EXECUTIVES
    TABLE 97. YPSOMED AG: COMPANY SNAPSHOT
    TABLE 98. YPSOMED AG: PRODUCT SEGMENTS
    TABLE 99. YPSOMED AG: PRODUCT PORTFOLIO
    TABLE 100. YPSOMED AG: KEY STRATERGIES
    TABLE 101. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
    TABLE 102. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    TABLE 103. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
    TABLE 104. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
    TABLE 105. MERCK GROUP: KEY EXECUTIVES
    TABLE 106. MERCK GROUP: COMPANY SNAPSHOT
    TABLE 107. MERCK GROUP: PRODUCT SEGMENTS
    TABLE 108. MERCK GROUP: PRODUCT PORTFOLIO
    TABLE 109. PFIZER INC.: KEY EXECUTIVES
    TABLE 110. PFIZER INC.: COMPANY SNAPSHOT
    TABLE 111. PFIZER INC.: PRODUCT SEGMENTS
    TABLE 112. PFIZER INC.: PRODUCT PORTFOLIO
    TABLE 113. NOVARTIS AG: KEY EXECUTIVES
    TABLE 114. NOVARTIS AG: COMPANY SNAPSHOT
    TABLE 115. NOVARTIS AG: PRODUCT SEGMENTS
    TABLE 116. NOVARTIS AG: PRODUCT PORTFOLIO
    TABLE 117. SANOFI: KEY EXECUTIVES
    TABLE 118. SANOFI: COMPANY SNAPSHOT
    TABLE 119. SANOFI: PRODUCT SEGMENTS
    TABLE 120. SANOFI: PRODUCT PORTFOLIO
    TABLE 121. NOVO NORDISK A/S: KEY EXECUTIVES
    TABLE 122. NOVO NORDISK A/S: COMPANY SNAPSHOT
    TABLE 123. NOVO NORDISK A/S: PRODUCT SEGMENTS
    TABLE 124. NOVO NORDISK A/S: PRODUCT PORTFOLIO
    TABLE 125. BIOCON: KEY EXECUTIVES
    TABLE 126. BIOCON: COMPANY SNAPSHOT
    TABLE 127. BIOCON: PRODUCT SEGMENTS
    TABLE 128. BIOCON: PRODUCT PORTFOLIO

  • LIST OF FIGURES

  • FIGURE 01. INJECTION PEN MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF INJECTION PEN MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN INJECTION PEN MARKET (2022-2031)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. LOW BARGAINING POWER OF BUYERS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW THREAT OF NEW ENTRANTS
    FIGURE 08. LOW INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALINJECTION PEN MARKET
    FIGURE 10. INJECTION PEN MARKET, BY TYPE, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR DISPOSABLE INJECTION PEN, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR REUSABLE INJECTION PEN, BY COUNTRY 2021-2031(%)
    FIGURE 13. INJECTION PEN MARKET, BY THERAPY, 2021(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR DIABETES, BY COUNTRY 2021-2031(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR GROWTH HORMONE, BY COUNTRY 2021-2031(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR OSTEOPOROSIS, BY COUNTRY 2021-2031(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR FERTILITY, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 19. INJECTION PEN MARKET, BY END USERS, 2021(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR HOME-CARE SETTINGS, BY COUNTRY 2021-2031(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF INJECTION PEN MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY 2021-2031(%)
    FIGURE 22. INJECTION PEN MARKET BY REGION, 2021
    FIGURE 23. U.S. INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 24. CANADA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 25. MEXICO INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 26. GERMANY INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 27. FRANCE INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 28. UK INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 29. ITALY INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 30. SPAIN INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 31. REST OF EUROPE INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 32. JAPAN INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 33. CHINA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 34. AUSTRALIA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 35. INDIA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 36. SOUTH KOREA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 37. REST OF ASIA-PACIFIC INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 38. BRAZIL INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 39. SAUDI ARABIA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 40. SOUTH AFRICA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 41. REST OF LAMEA INJECTION PEN MARKET, 2021-2031 ($MILLION)
    FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 46. COMPETITIVE DASHBOARD
    FIGURE 47. COMPETITIVE HEATMAP: INJECTION PEN MARKET
    FIGURE 48. TOP PLAYER POSITIONING, 2021
    FIGURE 49. ELI LILLY AND COMPANY: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 50. ELI LILLY AND COMPANY: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 51. ASTRAZENECA: NET SALES, 2020-2022 ($MILLION)
    FIGURE 52. ASTRAZENECA: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 53. YPSOMED AG: NET SALES, 2020-2022 ($MILLION)
    FIGURE 54. YPSOMED AG: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 55. YPSOMED AG: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 56. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 57. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 58. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 59. MERCK GROUP: NET SALES, 2020-2022 ($MILLION)
    FIGURE 60. MERCK GROUP: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 61. MERCK GROUP: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 62. PFIZER INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 63. PFIZER INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 64. PFIZER INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 65. NOVARTIS AG: NET SALES, 2020-2022 ($MILLION)
    FIGURE 66. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 67. NOVARTIS AG: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 68. SANOFI: NET SALES, 2020-2022 ($MILLION)
    FIGURE 69. SANOFI: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 70. SANOFI: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 71. NOVO NORDISK A/S: NET SALES, 2020-2022 ($MILLION)
    FIGURE 72. NOVO NORDISK A/S: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 73. NOVO NORDISK A/S: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 74. BIOCON: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 75. BIOCON: REVENUE SHARE BY SEGMENT, 2021 (%)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. An injection pen is a medical device used to administer injections. It consists of a needle, a syringe and a pen-like device with a plunger that controls the amount of medication administered. It is commonly used to administer insulin and other medications. There are disposable and reusable types of injection pens available in the market. Disposable pens are preloaded with drug and are thrown away after the drug cartridge is empty. Whereas reusable pens work with drug cartridges that can be loaded into the pen and then thrown away once the drug is used, leaving the pen ready for the next cartridge.

A. Increase in the prevalence of chronic disease, surge in awareness for self-injectable devices and rise in the technological advancement.

A. The factors that restrain the growth of the market are preference for alternative drug delivery mode and increase in number of needlestick injury.

A. Top companies such as Eli Lily and Company, Novo Nordisk A/S, Sanofi, Biocon, AstraZeneca, Pfizer Inc, Becton, Dickinson and Company, Ypsomed AG, Novartis AG and Merck KGaA held a high market position in 2021.

A. The total market value of the Injection Pen market is $37,899.00 million in 2021.

A. Yes, the competitive landscape is included in the injection pen market report.

A. The forecast period for Injection Pen market is 2022 to 2031.

A. The overall impact of COVID-19 remains positive on the injection pen market. Owing to an increase in the number of diabetes patients who are at higher risk of getting affected by COVID-19.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Injection Pen Market

Start reading instantly.
This Report and over 68,094+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers